Prospects and progress in cell therapy for acute respiratory distress syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospects and progress in cell therapy for acute respiratory distress syndrome

Published:2016-08-08 Issue:11 Volume:16 Page:1353-1360
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Cruz Fernanda F.,Weiss Daniel J.,Rocco Patricia R. M.

Funder

Brazilian Ministry of Health, and Coordination for the Improvement of Higher Level Personnel (CAPES)

Department of Science and Technology (DECIT)

The Centers of Excellence Program (PRONEX-FAPERJ)

Brazilian Council for Scientific and Technological Development (CNPq)

Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ)

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/14712598.2016.1218845

Reference99 articles.

1. ACUTE RESPIRATORY DISTRESS IN ADULTS

2. Happy 50th birthday ARDS!

3. The definition of ARDS revisited: 20 years later

4. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted transcriptomic analysis of synovial tissues from horses with septic arthritis treated with immune-activated mesenchymal stromal cells reveals induction of T-cell response pathways;Journal of the American Veterinary Medical Association;2024-02-03

2. MSC-Based Cell Therapy for COVID-19-Associated ARDS and Classical ARDS: Comparative Perspectives;Current Stem Cell Reports;2023-12-06

3. Anti-inflammatory therapies for acute respiratory distress syndrome;Expert Opinion on Investigational Drugs;2023-11-27

4. Engineered Extracellular Vesicles Derived from Dermal Fibroblasts Attenuate Inflammation in a Murine Model of Acute Lung Injury;Advanced Materials;2023-06-05

5. The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis;International Journal of Pharmaceutics;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3